For Southeastern United States FamiliesAlzheimer's Evaluation in Cuba in Southeastern United States
The Southeastern United States — including Florida, Mississippi, Louisiana, South Carolina, and neighboring states — is home to over 1.1 million Americans living with Alzheimer's. This region has some of the highest Alzheimer's prevalence rates in the nation, driven by large senior populations, significant African American communities (who face disproportionately high dementia risk), and high diabetes rates that compound cognitive decline. Miami, Tampa, and Fort Lauderdale offer the most convenient direct charter flights to Havana, while Atlanta, Charlotte, and New Orleans provide connecting flight options.
1.1M
Southeastern United States residents with Alzheimer's
6
states in region
1–5 hours (varies by departure city)
to Havana
Direct
flights available
What the Alzheimer's Evaluation Includes Across Southeastern United States
A comprehensive evaluation is the foundation of Cuba's Alzheimer's program. Without an accurate understanding of the patient's cognitive stage, type of dementia, and overall health, no treatment plan can be effective. Cuba's evaluation is more comprehensive than what most U.S. patients receive in a standard neurology appointment.
The evaluation includes: neuropsychological testing (a detailed assessment of memory, attention, language, executive function, and visuospatial skills), brain MRI review (to assess brain atrophy, vascular changes, and rule out other causes), comprehensive blood work (to rule out reversible causes of cognitive decline and assess overall health), and a multidisciplinary team assessment (neurologist, neuropsychologist, rehabilitation specialist, and internist).
Following the evaluation, the medical team provides a comprehensive report with the diagnosis, cognitive stage, treatment recommendations, and a personalized rehabilitation plan. This report is shared with the patient's U.S. neurologist for coordinated care. The evaluation is particularly valuable for patients with uncertain diagnoses, early-stage cognitive decline, or those seeking a second opinion before committing to a full treatment program.
No treatment currently cures Alzheimer's disease. Cuba's program aims to slow cognitive decline, maintain function, and improve quality of life. NeuroEPO is investigational and not FDA-approved. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.
State-by-State Guides
Alzheimer's Evaluation in Cuba by State in Southeastern United States
Select your state for detailed information about alzheimer's evaluation in cuba options, travel logistics, and state-specific resources.
City-Level Guides
Alzheimer's Evaluation in Cuba by City in Southeastern United States
Travel from Southeastern United States
Getting to Havana from Southeastern United States
Major Departure Airports
- Miami (MIA)
- Tampa (TPA)
- Fort Lauderdale (FLL)
- Atlanta (ATL)
- Charlotte (CLT)
- New Orleans (MSY)
Travel time: 1–5 hours (varies by departure city)
Travel Authorization
- • U.S. citizens can travel to Cuba under approved categories
- • SMC Salud provides letter of medical necessity
- • Treatment confirmation documentation included
- • Airport reception and ground transport in Havana
- • English-speaking coordinators throughout your stay
Frequently Asked Questions
Questions from Southeastern United States Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Alzheimer's Evaluation in Cuba in Cuba?
Submit your medical records for a complimentary review. Families across Southeastern United States receive a personalized treatment proposal within 5–10 business days.